COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 1051: Articles 10501-10510  | Next

The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: the case of the spike A222V mutation
Ginex, T., Marco-Marin, C., Wieczor, M., P. Mata, C., Krieger, J. M., Lopez-Redondo, M. L., Frances-Gomez, C., Ruiz-Rodriguez, P., Melero, R., Sanchez-Sorzano, C. O., Martinez, M., Gougeard, N., Forcada-Nadal, A., Zamora-Caballero, S., Gozalbo-Rovira, R., Sanz-Frasquet, C., Bravo, J., Rubio, V., Marina, A., The IBV-Covid19-Pipeline, , Geller, R., Comas, I., Gil, C., Coscolla, M., Orozco, M., Carazo, J.-M.
10.1101/2021.12.05.471263 — Posted: 2021-12-07
SARS-CoV-2 infection of olfactory epithelial cells and neurons drives acute lung injury and lethal COVID-19 in mice
Tang, A., Buccholz, D. W., Szigety, K., Imbhiaka, B., Gao, S., Frankfurter, M., Wang, M., Yang, J., Hewins, P., Mericko-Ishizuka, P., Leu, N., Sterling, S., Monreal, I., Sahler, J., August, A., Zhu, X., Jurado, K., Xu, M., Morrisey, E., Millar, S., Aguilar-Carreno, H., Kahn, M.
10.1101/2021.12.04.471245 — Posted: 2021-12-07
A nonrandomized phase 2 trial of oral thymic peptides in hospitalized patients with Covid-19
Ramos-Zaldivar, H. M., Reyes-Perdomo, K. G., Espinoza-Moreno, N. A., Dox-Cruz, E. T., Aguirre Urbina, T. C., Rivera Caballero, A. Y., Perdomo Dominguez, E. S., Pena Calix, S. G., Monterroso-Reyes, J. M., Caballero Vásquez, E. F., Zelaya Ortiz, T. S., Rodriguez-Machado, H. E., Forgas Solis, M. A., Sebilla Silva, I., Zavala Galeano, M. E., Morga Alvarado, A. A., Solis Medina, A. M. N., Guerrero-Diaz, L. M., Jimenez-Faraj, J. E., Perello Santos, C. A., Moncada Arita, W. A., Valdiviezo Montufar, D. F., Hernandez Sabillon, J. D., Sorto G., M. L., Padilla Navarro, X. X., Palomo-Bermudez, V. A.
10.1101/2021.12.05.21267318 — Posted: 2021-12-07
'It was brutal. It still is': A qualitative analysis of the challenges of bereavement during the COVID-19 pandemic reported in two national surveys
Torrens-Burton, A., Goss, S., Sutton, E., Barawi, K., Longo, M., Seddon, K., Carduff, E., Farnell, D. J., Nelson, A., Byrne, A., Selman, L. E., Harrop, E. J.
10.1101/2021.12.06.21267354 — Posted: 2021-12-07
Statistical Inferences and Analysis based on the COVID-19 data from the United States
Rethnakar, N.
10.1101/2021.11.30.21267096 — Posted: 2021-12-07 Discussion: Onsite
Stressors, Manifestations and Course of COVID-19 Related Distress Among Nurses and Midwives in Tasmania
Marsden, K. M., Porter, J. M., Robertson, I. K.
10.1101/2021.11.29.21266774 — Posted: 2021-12-07
The Petasites hybridus CO2-extract (Ze 339) blocks SARS-CoV-2 replication in vitro
Urda, L., Kreuter, M., Drewe, J., Boonen, G., Butterweck, V., Klimkait, T.
10.1101/2021.12.03.471068 — Posted: 2021-12-07
Pandemic-scale phylogenetics
Ye, C., Thornlow, B., Kramer, A. M., McBroome, J., Hinrichs, A. S., Corbett-Detig, R., Turakhia, Y.
10.1101/2021.12.03.470766 — Posted: 2021-12-06
Modeling the trajectory of SARS-CoV-2 spike protein evolution in continuous latent space using a neural network and Gaussian process
King, S., Chen, X. E., Ng, S. W. S., Rostin, K., Roberts, T., Hahn, S. V., Schwab, J. C., Sekhon, P., Kagieva, M., Reilly, T., Qi, R. C., Salman, P., Hong, R. J., Ma, E. J., Hallam, S. J.
10.1101/2021.12.04.471198 — Posted: 2021-12-06
Investigation of Vaccine Breakthrough Infections by Vaccine strategy during the Delta Variant Wave in France
Bal, A., Destras, G., Simon, B., Giannoli, J.-M., Morfin-sherpa, F., Lina, B., josset, l.
10.1101/2021.12.05.21267301 — Posted: 2021-12-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).